{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:58:46Z","timestamp":1768348726108,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.jpsychires.2012.04.020","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T05:36:41Z","timestamp":1337751401000},"page":"1053-1058","source":"Crossref","is-referenced-by-count":21,"title":["Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression"],"prefix":"10.1016","volume":"46","author":[{"given":"Helena P.G.","family":"Joaquim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leda L.","family":"Talib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orestes V.","family":"Forlenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Breno S.","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner F.","family":"Gattaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2012.04.020_bib38","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib1","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s00018-005-5597-y","article-title":"Glycogen synthase kinase 3B and Alzheimer's disease: pathophysiological and therapeutic significance","volume":"63","author":"Balaraman","year":"2006","journal-title":"Cellular and Molecular Life Science"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1073\/pnas.0711496105","article-title":"Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency","volume":"105","author":"Beaulieu","year":"2008","journal-title":"Proceedings of National Academy of Sciences"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/S1461145706006857","article-title":"Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs","volume":"10","author":"Beaulieu","year":"2007","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.jpsychires.2012.04.020_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrneurol.2011.60","article-title":"Depression and risk of developing dementia","volume":"7","author":"Byers","year":"2011","journal-title":"Nature Reviews Neurology"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.molbrainres.2005.03.004","article-title":"Inhibition of GSK3\u03b2 is a common event in neuroprotection by different survival factors","volume":"137","author":"Chin","year":"2005","journal-title":"Molecular Brain Research"},{"issue":"1","key":"10.1016\/j.jpsychires.2012.04.020_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neulet.2011.02.054","article-title":"Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study","volume":"494","author":"de Sousa","year":"2011","journal-title":"Neuroscience Letters"},{"issue":"2","key":"10.1016\/j.jpsychires.2012.04.020_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/gps.802","article-title":"Sertraline treatment of elderly patients with depression and cognitive impairment","volume":"18","author":"Devanand","year":"2003","journal-title":"International Journal of Geriatriac Psychiatry"},{"issue":"14","key":"10.1016\/j.jpsychires.2012.04.020_bib8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jpsychires.2010.02.008","article-title":"Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression","volume":"44","author":"Diniz","year":"2010","journal-title":"Journal of Psychiatric Research"},{"issue":"3","key":"10.1016\/j.jpsychires.2012.04.020_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3109\/15622970903544620","article-title":"Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression","volume":"11","author":"Diniz","year":"2010","journal-title":"The World Journal of Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2012.04.020_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/15622975.2010.551408","article-title":"Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment?","volume":"12","author":"Diniz","year":"2011","journal-title":"The World Journal of Biological Psychiatry"},{"issue":"12","key":"10.1016\/j.jpsychires.2012.04.020_bib11","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.biopsych.2006.03.082","article-title":"Hippocampal neurogenesis: regulation by stress and antidepressants","volume":"59","author":"Dranovsky","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1432-1033.1980.tb06059.x","article-title":"Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase","volume":"107","author":"Embi","year":"1980","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib13","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I disorders","author":"First","year":"2002"},{"issue":"1","key":"10.1016\/j.jpsychires.2012.04.020_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1017\/S1041610201007475","article-title":"Antidepressant efficacy and safety of low-dose sertraline and standard-dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial","volume":"13","author":"Forlenza","year":"2001","journal-title":"International Psychogeriatrics"},{"issue":"2","key":"10.1016\/j.jpsychires.2012.04.020_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jpsychires.2010.06.002","article-title":"Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease","volume":"45","author":"Forlenza","year":"2011","journal-title":"Journal of Psychiatric Research"},{"issue":"5","key":"10.1016\/j.jpsychires.2012.04.020_bib16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1192\/bjp.bp.110.080044","article-title":"Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial","volume":"198","author":"Forlenza","year":"2011","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib17","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/sj.npp.1300731","article-title":"Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs","volume":"30","author":"Gould","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","article-title":"The multifaceted roles of GSK3b in cellular signaling","volume":"65","author":"Grimes","year":"2001","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A\u00a0rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib20","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2174\/1389450110607011421","article-title":"Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions","volume":"7","author":"Jope","year":"2006","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","article-title":"Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics","volume":"32","author":"Jope","year":"2007","journal-title":"Neurochemistry Research"},{"issue":"1\u20132","key":"10.1016\/j.jpsychires.2012.04.020_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2008.11.020","article-title":"Antidepressants and dementia","volume":"117","author":"Kessing","year":"2009","journal-title":"Journal of Affective Disorder"},{"issue":"6","key":"10.1016\/j.jpsychires.2012.04.020_bib23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/YIC.0b013e32834ace0f","article-title":"Do continued antidepressants protect against dementia in patients with severe depressive disorder?","volume":"26","author":"Kessing","year":"2011","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib24","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","article-title":"A\u00a0molecular mechanism for the effect of lithium on development","volume":"93","author":"Klein","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib25","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/sj.npp.1300439","article-title":"In\u00a0vivo regulation of glycogen synthase kinase-3beta (GSK3-beta) by serotonergic activity in mouse brain","volume":"29","author":"Li","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biopsych.2006.02.027","article-title":"Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder","volume":"61","author":"Li","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1461145706006547","article-title":"Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics","volume":"10","author":"Li","year":"2007","journal-title":"International Journal Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.jpsychires.2012.04.020_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00406-008-0828-5","article-title":"Lithium reduces Gsk3b mRNA levels: implications for Alzheimer disease","volume":"259","author":"Mendes","year":"2009","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"1","key":"10.1016\/j.jpsychires.2012.04.020_bib29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00213-002-1379-5","article-title":"5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study","volume":"167","author":"Messa","year":"2003","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1601-183X.2007.00376.x","article-title":"Glycogen synthase kinase-3b, or a link between amyloid and tau pathology?","volume":"7","author":"Muyllaert","year":"2008","journal-title":"Genes, Brain and Behavior"},{"issue":"1","key":"10.1016\/j.jpsychires.2012.04.020_bib31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.expneurol.2007.01.037","article-title":"Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice","volume":"205","author":"Nelson","year":"2007","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1192\/bjp.bp.106.029868","article-title":"Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder","volume":"190","author":"Nunes","year":"2007","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jpsychires.2009.07.009","article-title":"Glycogen synthase kinase-3beta in the platelets of patients with mood disorders: effect of treatment","volume":"44","author":"Pandey","year":"2010","journal-title":"Journal of Psychiatry Research"},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2012.04.020_bib34","doi-asserted-by":"crossref","first-page":"S428","DOI":"10.1038\/bjp.2008.2","article-title":"The role of gsk-3 in synaptic plasticity","volume":"153","author":"Peineau","year":"2008","journal-title":"British Journal Pharmacology"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib35","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/npp.2010.43","article-title":"Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances","volume":"35","author":"Polter","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib36","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.1523\/JNEUROSCI.5216-05.2006","article-title":"Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania","volume":"26","author":"Prickaerts","year":"2006","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.jpsychires.2012.04.020_bib37","doi-asserted-by":"crossref","first-page":"14566","DOI":"10.1016\/S0021-9258(17)36661-9","article-title":"Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine\/threonine phosphorylation","volume":"269","author":"Wang","year":"1994","journal-title":"Journal of Biological Chemistry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395612001343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395612001343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T03:28:12Z","timestamp":1642303692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395612001343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0022395612001343"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2012.04.020","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}